CATALYST PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
官方登記資料
0位追蹤者
2002成立於
關於 CATALYST PHARMACEUTICALS, INC.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019.
Source: Wikipedia
產業Pharmaceutical Preparations
總部355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
成立時間2002
法律形式C Corporation
狀態營運中
專利4 項專利
VAMOROLONE SOLID ORAL DOSAGE FORMSWO2026035689A1 · 2026
METHOD FOR TREATING BOTULINUM TOXIN POISONINGWO2023023463A1 · 2023
關鍵數據
法律資訊
| 法定名稱 | CATALYST PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1369568在 SEC EDGAR 上查看 ↗ |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面